Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solasodine Ointment for Palmar Arsenic Keratosis
NCT04693000Phase 2Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Sep 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of solasodine in Arsenical keratosis, sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Arsenical Keratotic nodular size of the palm at 12 weeks. Status: unknown.
02
Drugs
solasodine
03
Conditions
Arsenical keratosis
Beyond the preview
Go deeper on NCT04693000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04693000.